RedHill Biopharma plans to implement ADS ratio change

RedHill Biopharma announced that it plans to implement a ratio change of the company’s American Depositary Shares to its non-traded ordinary shares from the current ratio of one ADS representing four hundred ordinary shares to a new ratio of one ADS representing ten thousand ordinary shares. The anticipated first date of the ratio change is on or about August 20, 2024, and the company’s ADSs will continue to be traded on the Nasdaq Capital Market under the symbol “RDHL” with a new CUSIP Number 757468301.